A Pharmaceutical Study of Varnya Mahakashaya Face Serum and its Effect On Melasma

A Pharmaceutical Study of Varnya Mahakashaya Face Serum With Mukta Pishti And Its Varnyakara Effect On Vyanga - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/11/076272

Enrollment

Registered

2024-11-05

Start date

Unknown

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L818- Other specified disorders of pigmentation

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients of either gender, caste, socio-economic status etc. with age group between 15-45yrs. Patients having classical clinical signs and symptoms of Vyanga- 1. Mukhamaagatya mandalam i.c. Circumscribed patches over face. 2. Tanukam i.e. Unelevated pigmentation of the facial skin. 3. Shyavam i.e. Dark brown pigmentation of the facial skin. 4. Neerujam i.e. PainlessÂ patches

Exclusion criteria

Exclusion criteria: Patients having pigmentation other than the face and other Kshudraroga. Pigmentation produced due to side effects of any other drug applied earlier. Patients below 15 years andÂ aboveÂ 45Â years. Individuals suffering from systemic pathologies like SLE, Cancer, severe hormonal imbalance and severe skin infection or allergies etc. Patients on medication of Hormonal Therapy. Pregnant or Breastfeeding mother. Patients having complains of painful pigmentedÂ patches.

Design outcomes

Primary

Measure	Time frame
Reduction in PigmentationTimepoint: 15Days,30 Days,45 Days	—

Secondary

Measure	Time frame
Complete Relief In HyperpigmentationTimepoint: 45 Days	—

Countries

India

Contacts

Public ContactDr Richa Pathak

Government P.G Ayurvedic College And Hospital,Varanasi

Dr.spandey2007@GMAIL.COM9417077401

Outcome results